Understanding patients' values and priorities in selecting cancer treatments: Developing a therapy preference scale.
作者信息
Bhatt Vijaya Raj
机构信息
Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, United States; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, United States.
出版信息
J Geriatr Oncol. 2019 Sep;10(5):677-679. doi: 10.1016/j.jgo.2018.11.005. Epub 2018 Nov 27.
Abstract
摘要
相似文献
1
Understanding patients' values and priorities in selecting cancer treatments: Developing a therapy preference scale.了解患者在选择癌症治疗方法时的价值观和优先事项：制定治疗偏好量表。
J Geriatr Oncol. 2019 Sep;10(5):677-679. doi: 10.1016/j.jgo.2018.11.005. Epub 2018 Nov 27.
2
Validated patient-reported outcome measurements for psoriasis may not reflect patients' current preferences.经验证的银屑病患者报告结局测量指标可能无法反映患者当前的偏好。
J Am Acad Dermatol. 2019 May;80(5):1445-1447.e4. doi: 10.1016/j.jaad.2018.09.019. Epub 2018 Sep 20.
3
Patients' Preferences in Non-Curable Cancer Disease.癌症不可治愈患者的偏好。
Oncol Res Treat. 2019;42(1-2):31-34. doi: 10.1159/000496120. Epub 2019 Jan 19.
4
Evolution and Predictors of Patient-Caregiver Concordance on States of Life-Sustaining Treatment Preferences over Terminally Ill Cancer Patients' Last Six Months of Life.终末期癌症患者生命最后六个月中维持生命治疗偏好状态的患者-照护者一致性的演变及其预测因素。
J Palliat Med. 2019 Jan;22(1):25-33. doi: 10.1089/jpm.2018.0307. Epub 2018 Sep 20.
5
Association between Advanced Cancer Patients' Perception of Curability and Patients' Characteristics, Decisional Control Preferences, Symptoms, and End-of-Life Quality Care Outcomes.晚期癌症患者对可治愈性的认知与患者特征、决策控制偏好、症状和临终期生活质量护理结局的关系。
J Palliat Med. 2018 Nov;21(11):1609-1616. doi: 10.1089/jpm.2018.0186. Epub 2018 Jul 26.
6
Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS-Preference (PROPr) Scoring System.患者报告结局测量信息系统（PROMIS）偏好评分系统：基于偏好的总结评分估算。
Med Decis Making. 2018 Aug;38(6):683-698. doi: 10.1177/0272989X18776637. Epub 2018 Jun 26.
7
Patient-preference disability assessment for disabling knee osteoarthritis: Validity and responsiveness of the McMaster-Toronto Arthritis Patient Preference Disability Questionnaire.患者对膝关节骨关节炎致残状况的偏好评估：麦克马斯特-多伦多关节炎患者偏好残疾问卷的有效性和反应性。
Ann Phys Rehabil Med. 2016 Sep;59(4):255-62. doi: 10.1016/j.rehab.2016.05.003. Epub 2016 Jul 21.
8
Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.实际和期望的决策角色与患者报告的护理质量的关联：癌症护理中的共同决策。
JAMA Oncol. 2015 Apr;1(1):50-8. doi: 10.1001/jamaoncol.2014.112.
9
Facilitating patient participation by embracing patients' preferences-A discussion.通过接受患者偏好促进患者参与——一场讨论
J Eval Clin Pract. 2019 Dec;25(6):1070-1073. doi: 10.1111/jep.13126. Epub 2019 Mar 27.
10
Shared decision-making in vascular surgery.血管外科学中的共同决策。
J Vasc Surg. 2019 Nov;70(5):1711-1715. doi: 10.1016/j.jvs.2019.03.002. Epub 2019 May 5.
引用本文的文献
1
A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML.一项针对老年急性髓系白血病患者进行老年评估指导下治疗强度选择的II期试验。
Am J Hematol. 2025 Jul;100(7):1163-1172. doi: 10.1002/ajh.27694. Epub 2025 Apr 29.
2
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients.肿瘤学中人工智能的机遇：临床医生和患者视角
JCO Oncol Pract. 2025 Mar 13:OP2400797. doi: 10.1200/OP-24-00797.
3
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.急性髓系白血病的体能评估：代表欧洲白血病网的专家小组建议
Blood Adv. 2025 May 13;9(9):2207-2220. doi: 10.1182/bloodadvances.2024013744.
4
Age and Sex-Based Differences in Therapy Preferences Among Patients with Cancer: Evidence from a Novel Therapy Preference Scale.癌症患者治疗偏好中的年龄和性别差异：来自新型治疗偏好量表的证据。
Res Sq. 2025 Jan 8:rs.3.rs-5743881. doi: 10.21203/rs.3.rs-5743881/v1.
5
Developing a National Study That Integrates the Geriatric Assessment into the Care of Older Patients with Myeloid Malignancies.制定一项将老年综合评估纳入老年血液系统恶性肿瘤患者治疗的全国性研究。
Curr Oncol Rep. 2024 Nov;26(11):1349-1354. doi: 10.1007/s11912-024-01600-y. Epub 2024 Sep 11.
6
Utilisation of endocrine therapy for cancer in Indigenous peoples: a systematic review and meta-analysis.原住民人群中癌症内分泌治疗的应用：系统评价和荟萃分析。
BMC Cancer. 2024 Jul 22;24(1):882. doi: 10.1186/s12885-024-12627-6.
7
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?癌症患者对全身性癌症治疗的偏好：偏好是否因年龄而异？
Future Oncol. 2022 Jan;18(3):311-321. doi: 10.2217/fon-2021-0260. Epub 2021 Nov 11.
8
Development and validation of the Therapy Preference Scale to understand patients´ systemic cancer treatment preferences.治疗偏好量表的制定与验证，以了解患者对系统性癌症治疗的偏好。
Future Oncol. 2021 Jan;17(1):37-44. doi: 10.2217/fon-2020-0497. Epub 2020 Dec 2.
9
Novel Treatment Paradigms in Acute Myeloid Leukemia.急性髓细胞白血病的新型治疗策略。
Clin Pharmacol Ther. 2020 Sep;108(3):506-514. doi: 10.1002/cpt.1962. Epub 2020 Aug 11.
10
Cancer in older adults: understanding cause and effects of chemotherapy-related toxicities.老年癌症患者：了解化疗相关毒性的原因及影响
Future Oncol. 2019 Aug;15(22):2557-2560. doi: 10.2217/fon-2019-0159. Epub 2019 Jul 24.
本文引用的文献
1
Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States.美国新诊断急性髓系白血病初始化疗的应用。
Blood Adv. 2018 Jun 12;2(11):1277-1282. doi: 10.1182/bloodadvances.2018019125.
2
Patients' priorities in selecting chronic lymphocytic leukemia treatments.患者在选择慢性淋巴细胞白血病治疗方法时的优先考虑因素。
Blood Adv. 2017 Oct 31;1(24):2176-2185. doi: 10.1182/bloodadvances.2017007294. eCollection 2017 Nov 14.
3
Initial therapy for acute myeloid leukemia in older patients: principles of care.老年患者急性髓系白血病的初始治疗：护理原则
Leuk Lymphoma. 2018 Jan;59(1):29-41. doi: 10.1080/10428194.2017.1323275. Epub 2017 Jun 2.
4
Patient experiences of acute myeloid leukemia: A qualitative study about diagnosis, illness understanding, and treatment decision-making.急性髓系白血病患者的经历：一项关于诊断、疾病认知和治疗决策的定性研究。
Psychooncology. 2017 Dec;26(12):2063-2068. doi: 10.1002/pon.4309. Epub 2016 Dec 19.
5
Patient assessment of treatment satisfaction: methods and practical issues.患者对治疗满意度的评估：方法与实际问题
Gut. 2004 May;53 Suppl 4(Suppl 4):iv40-4. doi: 10.1136/gut.2003.034322.
6
Understanding the treatment preferences of seriously ill patients.了解重症患者的治疗偏好。
N Engl J Med. 2002 Apr 4;346(14):1061-6. doi: 10.1056/NEJMsa012528.
7
Issues in the measurement of satisfaction with treatment.
Am J Manag Care. 1997 Apr;3(4):579-94.
Zotero 插件